logo

For the Inventor, By the Inventor

Germantown, MD, United States of America

Shoupeng Lai

This inventor holds 4 USPTO granted patents. Top assignee: Nanjing Leads Biolabs Co., Ltd.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shoupeng Lai. Retrieved from https://idiyas.com/inventor/shoupeng-lai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal4 out of 6 
 
Nanjing Leads Biolabs Co., Ltd.
 patents

Years Active: 2020-2024

Loading Chart...
4 patents (USPTO):Explore Patents
1. 11912777 - Antibodies binding TNFR2 and uses thereof (2024-02-27),
2. 11807683 - Antibody binding TIM-3 and use thereof (2023-11-07),
3. 11136394 - Antibody binding PD-1 and use thereof (2021-10-05),
4. 10844121 - Antibodies binding LAG-3 and uses thereof (2020-11-24),

Title: Shoupeng Lai: Innovator in Antibody Research

Introduction

Shoupeng Lai is a prominent inventor based in Germantown, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 4 patents, his work has the potential to impact various medical treatments and diagnostics.

Latest Patents

One of his latest patents is titled "Antibodies binding TNFR2 and uses thereof." This invention relates to a novel antibody and antibody fragment that specifically binds to TNFR2. It also includes a composition comprising the antibody or antibody fragment, as well as a nucleic acid encoding the antibody. The patent outlines the use of this antibody and fragment for treatment and diagnosis. Another significant patent is "Antibody binding TIM-3 and use thereof." This invention provides an isolated monoclonal antibody that specifically binds human TIM-3, along with a pharmaceutical composition comprising the antibody and its uses.

Career Highlights

Shoupeng Lai is associated with Nanjing Leads Biolabs Co., Ltd., where he continues to advance his research in antibody development. His innovative work has garnered attention in the scientific community, contributing to the understanding and treatment of various diseases.

Collaborations

He has collaborated with notable colleagues, including Xiaoqiang Kang and Xiao Huang, to further enhance the research and development of antibody-based therapies.

Conclusion

Shoupeng Lai's contributions to antibody research exemplify the innovative spirit of modern biotechnology. His patents reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…